InflaRx
IFRX
35 hedge funds and large institutions have $16.9M invested in InflaRx in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 6 closing their positions.
13,500% more call options, than puts
Call options by funds: $136K | Put options by funds: $1K
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
3% more funds holding
Funds holding: 34 → 35 (+1)
2.75% less ownership
Funds ownership: 28.86% → 26.11% (-2.7%)
14% less capital invested
Capital invested by funds: $19.6M → $16.9M (-$2.69M)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$259K |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$150K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$120K |
| 4 |
Morgan Stanley
New York
|
+$108K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$35.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$472K |
| 2 |
Two Sigma Investments
New York
|
-$205K |
| 3 |
Jane Street
New York
|
-$172K |
| 4 |
QC
Quadrature Capital
London,
United Kingdom
|
-$104K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$42.4K |
IFRX Hedge Fund Activity: Q1 2026 in Review
35 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q1 2026, worth a combined $16.9M — down 14% from $19.6M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new IFRX positions and 6 closed out — a net gain of 1 holder — while 7 added to existing stakes and 9 trimmed.
The largest buyer was Marshall Wace, adding an estimated $259K. The largest seller was Bank of America, cutting an estimated $472K.
- 35 institutional investors held InflaRx (IFRX) as of Q1 2026, up from 34 in Q4 2025.
- Funds reported $16.9M of InflaRx stock for Q1 2026, down 14% quarter-over-quarter.
- 7 funds opened new InflaRx positions in Q1 2026 and 6 closed out, a net change of +1 holder.
- The largest InflaRx buyer in Q1 2026 was Marshall Wace, an estimated $259K added.
- The largest InflaRx seller in Q1 2026 was Bank of America, an estimated $472K sold.
Based on aggregated 13F filings for Q1 2026.